Do current arterial hypertension treatment guidelines apply to systemic lupus erythematosus patients? A critical appraisal

Current HTN therapeutic guidelines, lacking data from large-scale clinical trials, may not adequately apply to SLE patients. The assessment of the aforementioned recommendations in randomized clinical trials is expected to confirm their value in reducing CV risk in SLE.